FDA ISSUES WARNING LETTERS TO RANBAXY LABORATORIES, IMPORT ALERT FOR DRUGS FROM TWO RANBAXY PLANTS IN INDIA
September 16, 2008
September 16, 2008
WASHINGTON, Sept. 16 -- The U.S. Department of Health & Human Services' Food & Drug Administration issued the following press release:
The Food and Drug Administration (FDA) today issued two Warning Letters to Ranbaxy Laboratories Ltd., of the Republic of India, and an Import Alert for generic drugs produced by Ranbaxy's Dewas and Paonta Sahib plants in India.
The Warning Letters identify the agency's concerns about deviations from U.S. current Good Manufact . . .
The Food and Drug Administration (FDA) today issued two Warning Letters to Ranbaxy Laboratories Ltd., of the Republic of India, and an Import Alert for generic drugs produced by Ranbaxy's Dewas and Paonta Sahib plants in India.
The Warning Letters identify the agency's concerns about deviations from U.S. current Good Manufact . . .